发明名称 RNA SEQUENCE-SPECIFIC MEDIATORS OF RNA INTERFERENCE
摘要 The present invention relates to a Drosophila in vitro system which was used to demonstrate that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Furthermore, when these 21-23 nt fragments are purified and added back to Drosophila extracts, they mediate RNA interference in the absence of long dsRNA. Thus, these 21-23 nt fragments are the sequence-specific mediators of RNA degradation. A molecular signal, which may be their specific length, must be present in these 21-23 nt fragments to recruit cellular factors involved in RNAi. This present invention encompasses these 21-23 nt fragments and their use for specifically inactivating gene function. The use of these fragments (or chemically synthesized oligonucleotides of the same or similar nature) enables the targeting of specific mRNAs for degradation in mammalian cells, where the use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response. This specific targeting of a particular gene function is useful in functional genomic and therapeutic applications.
申请公布号 PT1309726(E) 申请公布日期 2010.03.08
申请号 PT20010922870T 申请日期 2001.03.30
申请人 WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH;MAX-PLANCK-GES. ZUR FORDERUNG WISSENSCHAFTEN E.V.;MASSACHUSETTS INSTITUTE OF TECHNOLOGY;UNIVERSITY OF MASSACHUSETTS 发明人 THOMAS TUSCHL;PHILLIP A. SHARP;PHILLIP D. ZAMORE;DAVID P. BARTEL
分类号 C12N15/09;C12Q1/68;A61K31/7105;A61K38/00;A61K48/00;A61P43/00;C07H;C07H21/00;C12N;C12N1/00;C12N5/10;C12N15/10;C12N15/113;C12Q1/02 主分类号 C12N15/09
代理机构 代理人
主权项
地址
您可能感兴趣的专利